Glaxosmithkline Pharmaceuticals Ltd Quarterly Results

Gross Sales

974.37

949.42

1,010.77

814.65

929.8

Excise Duty

0

0

0

0

0

Net Sales

974.37

949.42

1,010.77

814.65

929.8

Other Operating Income

0

0

0

0

0

Other Income

40.68

35.07

39.23

35.64

32.23

Total Income

1,015.05

984.49

1,050

850.29

962.03

Total Expenditure

641.18

657.5

689.06

584.11

672.54

PBIDT

373.87

326.99

360.94

266.18

289.49

Interest

0.58

0.09

0.27

0.37

0.77

PBDT

373.29

326.9

360.67

265.81

288.72

Depreciation

14.72

18.8

16.86

16.41

18.1

Minority Interest Before NP

0

0

0

0

0

Tax

90.15

73.49

98.76

63.56

61.67

Deferred Tax

5.55

4.73

-7.45

3.51

14.47

Reported Profit After Tax

262.87

229.88

252.5

182.33

194.48

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

262.87

229.88

252.5

182.33

194.48

Extra-ordinary Items

0

0

3.34

0

1.72

Adjusted Profit After Extra-ordinary item

262.87

229.88

249.16

182.33

192.76

EPS (Unit Curr.)

15.52

13.57

14.67

10.76

11.37

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

240

120

0

0

Equity

169.41

169.41

169.41

169.41

169.41

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

38.37

34.44

35.7

32.67

31.13

PBDTM(%)

38.31

34.43

35.68

32.62

31.05

PATM(%)

26.97

24.21

24.98

22.38

20.91